Tag: Pfizer

23andMe Reaches Enrollment Goal for Lupus Research

23andMe reached another milestone earlier this month by completing enrollment in what is now one of the largest genetic studies of lupus in the world. As part of the Lupus Research Study, 23andMe and its collaborator in this study, Pfizer, Inc., have enrolled 5,000 people with lupus. Using genetic and ...

Read more

New Genetic Findings On Depression

In a new study, scientists have found genetic markers associated with depression in people of European descent. In what is by far the largest study of its kind focused on major depressive disorder, researchers from Pfizer, Massachusetts General Hospital and 23andMe identified 17 single nucleotide ...

Read more

Living With Crohn’s and Colitis

Anyone with inflammatory bowel disease has to be strong to handle the day-to-day challenges of living with the condition. You need even more moxie to take the extra step of being public about this serious and sometimes debilitating intestinal condition. One of those courageous few who’ve stepped out to ...

Read more

World IBD Day

23andMe, in collaboration with Pfizer Inc, is well on its way to enrolling 10,000 people living with Inflammatory Bowel Disease (IBD) to participate in research on this serious digestive condition, which includes both Crohn’s disease and ulcerative colitis. But we can’t begin our analysis of the data in ...

Read more

Learn About Our Lupus Research

With the start of Lupus Awareness Month, we’re offering up a snapshot of our growing lupus research community and one of the many people who has joined to make the work possible. Since we launched our Lupus Research Study we’re already more than halfway to reaching our goal of enrolling 5,000 people living ...

Read more

IBD Awareness Week

Today marks the beginning of Inflammatory Bowel Disease Awareness Week, established by Congress in 2011 to bring attention to the condition that affects more than 1.5 million Americans. As part of that effort, we’ll be putting up a few IBD related posts this week. Last year, 23andMe partnered with ...

Read more

Lupus and IBD Research Partnerships

Over the last year 23andMe has launched two research initiatives with Pfizer, one to study inflammatory bowel disease and the other to study lupus. We’re pretty optimistic about the work done so far as we continue to recruit patients to participate in these two important research projects, so it’s nice to ...

Read more

23andMe Hangs out with the Lupus Research Institute

Researchers know that genetics, as well as environmental and hormonal influences, play a role in the development of lupus, but we still have a lot to learn about this as-yet incurable autoimmune disease. This spring, 23andMe and Pfizer launched a study into the genetics of lupus. Working in collaboration ...

Read more

Living With Lupus

You want to know a little about what it’s like living with lupus, ask a first-time author, a “fiery Latina,” or Mrs. New York USA Universal. Those are just a few of the bloggers we’ve been following lately who each offer different insight on the day-in and day-out challenges of living with this chronic and ...

Read more

World IBD Day And Research

In less than a year’s time, 23andMe is more than halfway to its goal of enrolling 10,000 patients in its study of Inflammatory Bowel Disease (IBD), which will look more deeply at how genetics and environment affect the condition. As we recognize World IBD Day May 19th, we wanted to update you on our ...

Read more

Return to top